# Niocorp Developments Ltd: financial statements, quarterly

NB · Nasdaq · CIK 1512228 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/nb.md) · [Financials](/companies/nb/financials.md) · [Filings](/companies/nb/filings.md) · [Insiders](/companies/nb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [(2.1)](/filings/0001539497-24-002408.md) | [(1.2)](/filings/0001539497-25-000398.md) | [1.0](/filings/0001539497-24-000937.md) | [0.2 d](/filings/0001539497-24-001980.md) | [(0.0)](/filings/0001539497-24-002408.md) | [(0.0)](/filings/0001539497-25-000398.md) | [0.0](/filings/0001193125-26-223959.md) | [0.0 d](/filings/0001193125-26-402806.md) | not reported | [0.0](/filings/0001193125-26-041285.md) | [0.0](/filings/0001193125-26-223959.md) | [0.0 d](/filings/0001193125-26-402806.md) |
| Income tax | $m | [0.1](/filings/0001539497-24-002408.md) | [0.0 d](/filings/0001539497-25-000398.md) | [(0.2) d](/filings/0001539497-25-001285.md) | [(0.0) d](/filings/0001539497-25-002331.md) | not reported | [0.0](/filings/0001193125-26-041285.md) | [0.0](/filings/0001193125-26-223959.md) | [0.0 d](/filings/0001193125-26-402806.md) | not reported | [0.0](/filings/0001193125-26-041285.md) | [0.0](/filings/0001193125-26-223959.md) | [0.0 d](/filings/0001193125-26-402806.md) |
| Net income | $m | [(3.4)](/filings/0001539497-24-002408.md) | [(3.4)](/filings/0001539497-24-000311.md) | [(4.1)](/filings/0001539497-25-001285.md) | [(1.3) d](/filings/0001539497-25-002331.md) | [(2.1)](/filings/0001539497-25-002940.md) | [(0.5)](/filings/0001193125-26-041285.md) | [(5.3)](/filings/0001193125-26-223959.md) | [(9.6) d](/filings/0001193125-26-402806.md) | [(43.5)](/filings/0001539497-25-002940.md) | [(0.6)](/filings/0001193125-26-041285.md) | [0.7](/filings/0001193125-26-223959.md) | [(5.9) d](/filings/0001193125-26-402806.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [(0.01)](/filings/0001193125-26-041285.md) | [(0.11)](/filings/0001193125-26-223959.md) | not reported | not reported | [0.00](/filings/0001193125-26-041285.md) | [0.01](/filings/0001193125-26-223959.md) | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [(0.01)](/filings/0001193125-26-041285.md) | [(0.11)](/filings/0001193125-26-223959.md) | not reported | not reported | [0.00](/filings/0001193125-26-041285.md) | [0.01](/filings/0001193125-26-223959.md) | not reported |

- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.1](/filings/0001539497-23-001892.md) | [0.6](/filings/0001539497-24-000311.md) | [0.2](/filings/0001539497-24-000937.md) | [2.0](/filings/0001539497-25-002331.md) | [0.2](/filings/0001539497-24-002408.md) | [0.5](/filings/0001539497-25-000398.md) | [1.3](/filings/0001539497-25-001285.md) | [25.6](/filings/0001193125-26-402806.md) | [163](/filings/0001539497-25-002940.md) | [306](/filings/0001193125-26-041285.md) | [419](/filings/0001193125-26-223959.md) | [415](/filings/0001193125-26-402806.md) |
| Current assets | $m | [2.1](/filings/0001539497-23-001892.md) | [1.1](/filings/0001539497-24-000311.md) | [0.5](/filings/0001539497-24-000937.md) | [2.9](/filings/0001539497-25-002331.md) | [1.2](/filings/0001539497-24-002408.md) | [0.7](/filings/0001539497-25-000398.md) | [1.4](/filings/0001539497-25-001285.md) | [26.7](/filings/0001193125-26-402806.md) | [164](/filings/0001539497-25-002940.md) | [308](/filings/0001193125-26-041285.md) | [424](/filings/0001193125-26-223959.md) | [419](/filings/0001193125-26-402806.md) |
| Total assets | $m | [19.3](/filings/0001539497-23-001892.md) | [18.2](/filings/0001539497-24-000311.md) | [17.6](/filings/0001539497-24-000937.md) | [20.1](/filings/0001539497-25-002331.md) | [18.3](/filings/0001539497-24-002408.md) | [17.9](/filings/0001539497-25-000398.md) | [18.5](/filings/0001539497-25-001285.md) | [43.8](/filings/0001193125-26-402806.md) | [195](/filings/0001539497-25-002940.md) | [348](/filings/0001193125-26-041285.md) | [469](/filings/0001193125-26-223959.md) | [467](/filings/0001193125-26-402806.md) |
| Current liabilities | $m | [12.6](/filings/0001539497-23-001892.md) | [11.7](/filings/0001539497-24-000311.md) | [9.1](/filings/0001539497-24-000937.md) | [12.0](/filings/0001539497-25-002331.md) | [8.1](/filings/0001539497-24-002408.md) | [3.8](/filings/0001539497-25-000398.md) | [1.1](/filings/0001539497-25-001285.md) | [1.9](/filings/0001193125-26-402806.md) | [4.0](/filings/0001539497-25-002940.md) | [9.8](/filings/0001193125-26-041285.md) | [13.6](/filings/0001193125-26-223959.md) | [16.5](/filings/0001193125-26-402806.md) |
| Total liabilities | $m | [24.2](/filings/0001539497-23-001892.md) | [22.5](/filings/0001539497-24-000311.md) | [18.1](/filings/0001539497-24-000937.md) | [17.5](/filings/0001539497-25-002331.md) | [14.4](/filings/0001539497-24-002408.md) | [9.6](/filings/0001539497-25-000398.md) | [9.7](/filings/0001539497-25-001285.md) | [14.7](/filings/0001193125-26-402806.md) | [43.2](/filings/0001539497-25-002940.md) | [40.0](/filings/0001193125-26-041285.md) | [34.6](/filings/0001193125-26-223959.md) | [37.1](/filings/0001193125-26-402806.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(6.9)](/filings/0001539497-23-001892.md) | [(6.1)](/filings/0001539497-24-000311.md) | [(2.1)](/filings/0001539497-24-000937.md) | [1.0](/filings/0001193125-26-402806.md) | [2.4](/filings/0001193125-26-041285.md) | [6.9](/filings/0001193125-26-223959.md) | [7.5](/filings/0001193125-26-223959.md) | [28.3](/filings/0001193125-26-402806.md) | [152](/filings/0001193125-26-041285.md) | [309](/filings/0001193125-26-223959.md) | [435](/filings/0001193125-26-223959.md) | [431](/filings/0001193125-26-402806.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,737)](/filings/0001539497-24-002408.md) | [(1,888) d](/filings/0001539497-25-000398.md) | [(991) d](/filings/0001539497-25-001285.md) | [(6,116) d](/filings/0001539497-25-002331.md) | [(642)](/filings/0001539497-25-002940.md) | [(1,338) d](/filings/0001193125-26-041285.md) | [(3,895) d](/filings/0001193125-26-223959.md) | [(4,787) d](/filings/0001193125-26-402806.md) | [(6,669)](/filings/0001539497-25-002940.md) | [(838) d](/filings/0001193125-26-041285.md) | [(4,380) d](/filings/0001193125-26-223959.md) | [(4,011) d](/filings/0001193125-26-402806.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [41.2](/filings/0001193125-26-041285.md) | [45.9](/filings/0001193125-26-223959.md) | [117](/filings/0001193125-26-041285.md) | [136](/filings/0001193125-26-223959.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 145,849,630 at 2026-09-25, from the cover of the [10-K filed 2026-09-25](/filings/0001193125-26-402806.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.